Oral toxicity management in head and neck cancer patients treated with chemotherapy and radiation: Dental pathologies and osteoradionecrosis (Part 1) literature review and consensus statement

Critical Reviews in Oncology/Hematology

Volumn 97, Issue , 2016, Pages 131-142

  Buglione, Michela ^a   Cavagnini, Roberta ^a   Di Rosario, Federico ^b   Sottocornola, Lara ^b   Maddalo, Marta ^a   Vassalli, Lucia ^b   Grisanti, Salvatore ^b   Salgarello, Stefano ^b   Orlandi, Ester ^c   Paganelli, Corrado ^b   Majorana, Alessandra ^b   Gastaldi, Giorgio ^b   Bossi, Paolo ^c   Berruti, Alfredo ^b   Pavanato, Giovanni ^d   Nicolai, Piero ^b   Maroldi, Roberto ^b   Barasch, Andrei ^e   Russi, Elvio G ^f   Raber Durlacher, Judith ^g,h   Murphy, Barbara ⁱ   Magrini, Stefano M ^a   more..

^a UNIVERSITY OF BRESCIA   (Italy)

^b UNIVERSITY OF BRESCIA   (Italy)

^c NATIONAL CANCER INSTITUTE   (Italy)

^d Ospedale S Maria della Misericordia   (Italy)

^e UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^f Radiation Oncology Department   (Italy)

^g ACADEMIC MEDICAL CENTER   (Netherlands)

^h UNIVERSITY OF AMSTERDAM   (Netherlands)

ⁱ VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Caries; Dental pathology; Head and neck cancer; Osteo radionecrosis; Radionecrosis; Radiotherapy

Indexed keywords

ANTINEOPLASTIC AGENT;

BONE BIOPSY; BONE NECROSIS; CANCER CHEMOTHERAPY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CLINICAL ASSESSMENT; CLINICAL EVALUATION; DENTAL CARIES; DISEASE ASSOCIATION; FOLLOW UP; HEAD AND NECK CANCER; HUMAN; HYPOSALIVATION; MOUTH EXAMINATION; MOUTH HYGIENE; ORAL MUCOSITIS; RADIATION DERMATITIS; RADIATION FIELD; REVIEW; RISK FACTOR; SALIVARY GLAND DISEASE; SALVAGE THERAPY; SYSTEMATIC REVIEW; TASTE DISORDER; TOOTH EXTRACTION; TOOTH IMPLANT; TREATMENT PLANNING; TRISMUS; XEROSTOMIA; ADVERSE EFFECTS; CONSENSUS DEVELOPMENT; DELPHI STUDY; HEAD AND NECK NEOPLASMS; OSTEORADIONECROSIS; RADIATION INJURIES; RADIOTHERAPY; STOMATITIS;

ANTINEOPLASTIC AGENTS; DELPHI TECHNIQUE; DENTAL CARIES; HEAD AND NECK NEOPLASMS; HUMANS; OSTEORADIONECROSIS; RADIATION INJURIES; RADIOTHERAPY; STOMATITIS; TRISMUS; XEROSTOMIA;

EID: 84952637664     PISSN: 10408428     EISSN: 18790461     Source Type: Journal    
DOI: 10.1016/j.critrevonc.2015.08.010     Document Type: Review

References (124)

1. Ammajan R.R., Joseph R., Rajeev R., Choudhary K., Vidhyadharan K. Assessment of periodontal changes in patients undergoing radiotherapy for head and neck malignancy: a hospital-based study. J. Cancer Res. Ther. 2013, 9:630-637. 10.4103/0973-1482.126461.
2. Ben-David M.A., Diamante M., Radawski J.D., Vineberg K.A., Stroup C., Murdoch-Kinch C.-A., et al. Lack of osteoradionecrosis of the mandible after intensity-modulated radiotherapy for head and neck cancer: likely contributions of both dental care and improved dose distributions. Int. J. Radiat. Oncol. Biol. Phys. 2007, 68:396-402. 10.1016/j.ijrobp.2006.11.059.
3. Bensadoun R.-J., Riesenbeck D., Lockhart P.B., Elting L.S., Spijkervet F.K.L., Brennan M.T., et al. A systematic review of trismus induced by cancer therapies in head and neck cancer patients. Support Care Cancer 2010, 18:1033-1038. 10.1007/s00520-010-0847-4.
4. Beumer J., Seto B. Dental extractions in the irradiated patient. Spec. Care Dent. Off. Publ. Am. Assoc. Hosp. Dent. Acad. Dent. Handicap Am. Soc. Geriatr. Dent. 1981, 1:166-173.
5. Beumer J., Harrison R., Sanders B., Kurrasch M. Preradiation dental extractions and the incidence of bone necrosis. Head Neck Surg. 1983, 5:514-521. 10.1002/hed.2890050611.
6. Beumer J., Harrison R., Sanders B., Kurrasch M. Osteoradionecrosis predisposing factors and outcomes of therapy. Head Neck Surg. 1984, 6:819-827.
7. Bhide S.A., Gulliford S., Kazi R., El-Hariry I., Newbold K., Harrington K.J., et al. Correlation between dose to the pharyngeal constrictors and patient quality of life and late dysphagia following chemo-IMRT for head and neck cancer. Radiother. Oncol. J. Eur. Soc. Ther. Radiol. Oncol. 2009, 93:539-544.
8. Bhide S.A., Gulliford S., Schick U., Miah A., Zaidi S., Newbold K., et al. Dose-response analysis of acute oral mucositis and pharyngeal dysphagia in patients receiving induction chemotherapy followed by concomitant chemo-IMRT for head and neck cancer. Radiother. Oncol. J. Eur. Soc. Ther. Radiol. Oncol. 2012, 10.1016/j.radonc.2011.12.027.
9. Braam P.M., Roesink J.M., Raaijmakers C.P., Busschers W.B., Terhaard C.H. Quality of life and salivary output in patients with head-and-neck cancer five years after radiotherapy. Radiat. Oncol. 2007, 2:3. 10.1186/1748-717X-2-3.
10. Bruins, H.H., Hubert, H., 2001. Preradiation dental decisions in patients with head and neck cancer.
11. Cartmill B., Cornwell P., Ward E., Davidson W., Nund R., Bettington C., et al. Emerging understanding of dosimetric factors impacting on dysphagia and nutrition following radiotherapy for oropharyngeal cancer. Head Neck 2012, n/a-n/a. 10.1002/hed.23040.
12. Caudell J.J., Schaner P.E., Desmond R.A., Meredith R.F., Spencer S.A., Bonner J.A. Dosimetric factors associated with long-term dysphagia after definitive radiotherapy for squamous cell carcinoma of the head and neck. Int. J. Radiat. Oncol. Biol. Phys. 2010, 76:403-409.
13. Chavez J.A., Adkinson C.D. Adjunctive hyperbaric oxygen in irradiated patients requiring dental extractions: outcomes and complications. J. Oral Maxillofac. Surg. 2001, 59:518-522. 10.1053/joms.2001.22680.
14. Cheng V.S.T., Wang C.C. Osteoradionecrosis of the mandible resulting from external megavoltage radiation therapy. Radiology 1974, 112:685-689. 10.1148/112.3.685.
15. Chong J., Hinckley L.K., Ginsberg L.E. Masticator space abnormalities associated with mandibular osteoradionecrosis: MR and CT findings in five patients. Am. J. Neuroradiol. 2000, 21:175-178.
16. Chrcanovic B.R., Reher P., Sousa A.A., Harris M. Osteoradionecrosis of the jaws-a current overview-part 1: physiopathology and risk and predisposing factors. Oral Maxillofac. Surg. 2010, 14:3-16. 10.1007/s10006-009-0198-9.
17. Chrcanovic B.R., Albrektsson T., Wennerberg A. Dental implants in irradiated versus non-irradiated patients: a meta-analysis. Head Neck 2014, 10.1002/hed.23875.
18. Chuang S.-K. Limited evidence to demonstrate that the use of hyperbaric oxygen (HBO) therapy reduces the incidence of osteoradionecrosis in irradiated patients requiring tooth extraction. J. Evid. Based Dent. Pract. 2012, 12:248-250. 10.1016/S1532-3382(12)70047-7.
19. Clark C.H., Miles E.A., Urbano M.T.G., Bhide S.A., Bidmead A.M., Harrington K.J., et al. Pre-trial quality assurance processes for an intensity-modulated radiation therapy (IMRT) trial: PARSPORT, a UK multicentre Phase III trial comparing conventional radiotherapy and parotid-sparing IMRT for locally advanced head and neck cancer. Br. J. Radiol. 2009, 82:585-594. 10.1259/bjr/31966505.
20. Costantino P.D., Friedman C.D., Steinberg M.J. Irradiated bone and its management. Otolaryngol. Clin. N. Am. 1995, 28:1021-1038.
21. Cox J.D., Stetz J., Pajak T.F. Toxicity criteria of the radiation therapy oncology group (RTOG) and the European organization for research and treatment of cancer (EORTC). Int. J. Radiat. Oncol. 1995, 31:1341-1346. 10.1016/0360-3016(95)00060-C.
22. Curi M.M., Dib L.L. Osteoradionecrosis of the jaws: a retrospective study of the background factors and treatment in 104 cases. J. Oral Maxillofac. Surg. 1997, 55:540-544. (discussion 545-6).
23. Delanian S., Lefaix J.-L. The radiation-induced fibroatrophic process: therapeutic perspective via the antioxidant pathway. Radiother. Oncol. 2004, 73:119-131. 10.1016/j.radonc.2004.08.021.
24. Deshpande S.S., Thakur M.H., Dholam K., Mahajan A., Arya S., Juvekar S. Osteoradionecrosis of the mandible: through a radiologist's eyes. Clin. Radiol. 2015, 70:197-205. 10.1016/j.crad.2014.09.012.
25. Dirix P., Nuyts S. Evidence-based organ-sparing radiotherapy in head and neck cancer. Lancet Oncol 2010, 11:85-91. 10.1016/S1470-2045(09)70231-1.
26. Eisbruch A., Ten Haken R.K., Kim H.M., Marsh L.H., Ship J.A. Dose, volume, and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer. Int. J. Radiat. Oncol. 1999, 45:577-587. 10.1016/S0360-3016(99)00247-3.
27. Eisbruch A., Schwartz M., Rasch C., Vineberg K., Damen E., Van As C.J., et al. Dysphagia and aspiration after chemoradiotherapy for head-and-neck cancer: which anatomic structures are affected and can they be spared by IMRT?. Int. J. Radiat. Oncol. 2004, 60:1425-1439. 10.1016/j.ijrobp.2004.05.050.
28. Eisbruch A., Kim H.M., Feng F.Y., Lyden T.H., Haxer M.J., Feng M., et al. Chemo-IMRT of oropharyngeal cancer aiming to reduce dysphagia: swallowing organs late complication probabilities and dosimetric correlates. Int. J. Radiat. Oncol. Biol. Phys. 2011, 81:e93-e99. 10.1016/j.ijrobp.2010.12.067.
29. Elad S., Meyerowitz C. Late oral adverse effects of cancer treatments. ALERT 2: Normal Tissue Specific Sites and Systems:141-166.
30. Eliyas S., Al-Khayatt A., Porter R.W., Briggs P. Den Tal Extractions Prior to Radiotherapy to the Jaws for Reducing Post-radiotherapy Dental Complications. Cochrane Database Syst. Rev 1996, John Wiley & Sons, Ltd.
31. Epstein J.B., Rea G., Wong F.L., Spinelli J., Stevenson-Moore P. Osteonecrosis study of the relationship of dental extractions in patients receiving radiotherapy. Head Neck Surg. 1987, 10:48-54.
32. Epstein J.B., Wong F.L., Stevenson-Moore P. Osteoradionecrosis clinical experience and a proposal for classification. J. Oral Maxillofac. Surg. 1987, 45:104-110.
33. Epstein J.B., Lunn R., Le N., Stevenson-Moore P. Periodontal attachment loss in patients after head and neck radiation therapy. Oral. Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 1998, 86:673-677.
34. Esposito M., Worthington H.V. Interventions for replacing missing teeth: hyperbaric oxygen therapy for irradiated patients who require dental implants. Cochrane Database Syst. Rev. 2013, 9:CD003603. 10.1002/14651858.CD003603.pub3.
35. Fischbein N.J., AAssar O.S., Caputo G.R., Kaplan M.J., Singer M.I., Price D.C., et al. Clinical utility of positron emission tomography with 18F-fluorodeoxyglucose in detecting residual/recurrent squamous cell carcinoma of the head and neck. Am. J. Neuroradiol. 1998, 19:1189-1196.
36. Franzén L., Rosenquist J.B., Rosenquist K.I., Gustafsson I. Oral implant rehabilitation of patients with oral malignancies treated with radiotherapy and surgery without adjunctive hyperbaric oxygen. Int. J. Oral Maxillofac. Implants 1995, 10:183-187.
37. Friedlander A.H., Tajima T., Garrett N.R. Panoramic radiographs of head and neck cancer patients are often evidence of carotid artery atherosclerotic lesions: a sign of high-risk comorbid illness. J. Oral Maxillofac. Surg. 2012, 70:1096-1101. 10.1016/j.joms.2011.05.020.
38. Garden A.S., Morrison W.H., Wong P.-F., Tung S.S., Rosenthal D.I., Dong L., et al. Disease-control rates following intensity-modulated radiation therapy for small primary oropharyngeal carcinoma. Int. J. Radiat. Oncol. 2007, 67:438-444. 10.1016/j.ijrobp.2006.08.078.
39. Gevorgyan A., Wong K., Poon I., Blanas N., Enepekides D.J., Higgins K.M. Osteoradionecrosis of the mandible: a case series at a single institution. J. Otolaryngol. Head Neck Surg. 2013, 42:46. 10.1186/1916-0216-42-46.
40. Goldstein M., Maxymiw W.G., Cummings B.J., Wood R.E. The effects of antitumor irradiation on mandibular opening and mobility: a prospective study of 58 patients. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 1999, 88:365-373. 10.1016/S1079-2104(99)70044-2.
41. Granström G., Tjellström A., Albrektsson T. Postimplantation irradiation for head and neck cancer treatment. Int. J. Oral Maxillofac. Implants 1993, 8:495-501.
42. Hancock P.J., Epstein J.B., Sadler G.R. Oral and dental management related to radiation therapy for head and neck cancer. J. Can. Dent. Assoc. 2003, 69:585-590.
43. Harris M. The conservative management of osteoradionecrosis of the mandible with ultrasound therapy. Br. J. Oral Maxillofac. Surg. 1992, 30:313-318.
44. Hermans R., Fossion E., Ioannides C., Van den Bogaert W., Ghekiere J., Baert A.L. CT findings in osteoradionecrosis of the mandible. Skelet. Radiol. 1996, 25:31-36.
45. Hermans R. Imaging of mandibular osteoradionecrosis. Neuroimaging Clin. N. Am. 2003, 13:597-604.
46. Hong C.H.L., Napeñas J.J., Hodgson B.D., Stokman M.A., Mathers-Stauffer V., Elting L.S., et al. A systematic review of dental disease in patients undergoing cancer therapy. Support Care Cancer 2010, 18:1007-1021. 10.1007/s00520-010-0873-2.
47. Horiot J.C., Bone M.C., Ibrahim E., Castro J.R. Systematic dental management in head and neck irradiation. Int. J. Radiat. Oncol. 1981, 7:1025-1029. 10.1016/0360-3016(81)90154-1.
48. Hu J.Y., Li Y.Q., Smales R.J., Yip K.H.K. Restoration of teeth with more-viscous glass ionomer cements following radiation-induced caries. Int. Dent. J. 2002, 52:445-448.
49. Hung G.-U., Tsai S.-C., Lin W.-Y. Extraordinarily high F-18 FDG uptake caused by radiation necrosis in a patient with nasopharyngeal carcinoma. Clin. Nucl. Med. 2005, 30:558-559.
50. Jacobsson M., Nannmark U., Turesson I. Acute microvascular reactions to ionizing irradiation in bone-anchored titanium implants: a vital microscopic study. Int. J. Oral Maxillofac. Implants 1987, 2:193-196.
51. Jellema A.P., Doornaert P., Slotman B.J., Rene Leemans C., Langendijk J.A. Does radiation dose to the salivary glands and oral cavity predict patient-rated xerostomia and sticky saliva in head and neck cancer patients treated with curative radiotherapy?. Radiother. Oncol. 2005, 77:164-171. 10.1016/j.radonc.2005.10.002.
52. Jensen K., Lambertsen K., Grau C. Late swallowing dysfunction and dysphagia after radiotherapy for pharynx cancer: Frequency, intensity and correlation with dose and volume parameters. Radiother. Oncol. J. Eur. Soc. Ther. Radiol. Oncol. 2007, 85:74-82.
53. Johnson J., van As-Brooks C.J., Fagerberg-Mohlin B., Finizia C. Trismus in head and neck cancer patients in Sweden: incidence and risk factors. Med. Sci. Monit. Int. Med. J. Exp. Clin. Res. 2010, 16:CR278-CR282.
54. Kao C.H., ChangLai S.P., Chieng P.U., Yen R.F., Yen T.C. Detection of recurrent or persistent nasopharyngeal carcinomas after radiotherapy with 18-fluoro-2-deoxyglucose positron emission tomography and comparison with computed tomography. J. Clin. Oncol. 1998, 16:3550-3555.
55. Klein M.O., Grötz K.A., Walter C., Wegener J., Wagner W., Al-Nawas B. Functional rehabilitation of mandibular continuity defects using autologous bone and dental implants-prognostic value of bone origin, radiation therapy and implant dimensions. Eur. Surg. Res. 2009, 43:269-275. 10.1159/000229027.
56. Koga D., Salvajoli J., Alves F. Dental extractions and radiotherapy in head and neck oncology: review of the literature. Oral Dis. 2008, 14:40-44. 10.1111/j.1601-0825.2006.01351.x.
57. LENT SOMA scales for all anatomic sites, 1995. Int. J. Radiat. Oncol. Biol. Phys. 31, 1049-1091.
58. Lambade P.N., Lambade D., Goel M. Osteoradionecrosis of the mandible: a review. Oral Maxillofac. Surg. 2013, 17:243-249. 10.1007/s10006-012-0363-4.
59. Landes C.A., Kovács A.F. Comparison of early telescope loading of non-submerged ITI implants in irradiated and non-irradiated oral cancer patients. Clin. Oral Implants Res. 2006, 17:367-374. 10.1111/j.1600-0501.2005.01227.x.
60. Levendag P.C., Teguh D.N., Voet P., van der Est H., Noever I., de Kruijf W.J.M., et al. Dysphagia disorders in patients with cancer of the oropharynx are significantly affected by the radiation therapy dose to the superior and middle constrictor muscle: a dose-effect relationship. Radiother. Oncol. 2007, 85:64-73. 10.1016/j.radonc.2007.07.009.
61. Li B., Li D., Lau D.H., Farwell D.G., Luu Q., Rocke D.M., et al. Clinical-dosimetric analysis of measures of dysphagia including gastrostomy-tube dependence among head and neck cancer patients treated definitively by intensity-modulated radiotherapy with concurrent chemotherapy. Radiat. Oncol. Lond. Engl. 2009, 4:52. 10.1186/1748-717X-4-52.
62. Liu S.-H., Chang J.T., Ng S.-H., Chan S.-C., Yen T.-C. False positive fluorine-18 fluorodeoxy-D-glucose positron emission tomography finding caused by osteoradionecrosis in a nasopharyngeal carcinoma patient. Br. J. Radiol. 2004, 77:257-260.
63. Loblaw D.A., Prestrud A.A., Somerfield M.R., Oliver T.K., Brouwers M.C., Nam R.K. American Society of Clinical Oncology Clinical Practice Guidelines: formal systematic review-based consensus methodology. J. Clin. Oncol. 2012, 30:3136-3140. 10.1200/JCO.2012.42.0489.
64. Logemann, J.A., 1997. Evaluation and Treatment of Swallowing Disorders 2 Sub. Pro ed.
65. Lyons A., Ghazali N. Osteoradionecrosis of the jaws: current understanding of its pathophysiology and treatment. Br. J. Oral Maxillofac. Surg. 2008, 46:653-660. 10.1016/j.bjoms.2008.04.006.
66. Lyons A., Osher J., Warner E., Kumar R., Brennan P.A. Osteoradionecrosis-a review of current concepts in defining the extent of the disease and a new classification proposal. Br. J. Oral Maxillofac. Surg. 2014, 52:392-395. 10.1016/j.bjoms.2014.02.017.
67. Manon R., Meyrs J., Khuntia D., Harari P.M., Levendag P., Teguh D.N. Oral cavity cancer and oropharynx. Perez Bradys Princ. Pract. Radiat. Oncol. Fifth Plus Integrated Content Website 2007, 891-957. Lippincott, Williams & Wilkins. E.C. Halperin, C.A. Perez, L.W. Brady, D.E. Wazer, C. Freeman, L.R. Prosnitz (Eds.).
68. Marx R.E., Johnson R.P. Studies in the radiobiology of osteoradionecrosis and their clinical significance. Oral Surg. Oral Med. Oral Pathol. 1987, 64:379-390.
69. Marx R.E., Johnson R.P., Kline S.N. Prevention of osteoradionecrosis: a randomized prospective clinical trial of hyperbaric oxygen versus penicillin. J. Am. Dent. Assoc. 1985, 111:49-54.
70. Marx R.E. A new concept in the treatment of osteoradionecrosis. J. Oral Maxillofac. Surg. 1983, 41:351-357.
71. Marx R.E. Osteoradionecrosis a new concept of its pathophysiology. J. Oral Maxillofac. Surg. 1983, 41:283-288.
72. Maxymiw W.G., Wood R.E., Liu F.F. Postradiation dental extractions without hyperbaric oxygen. Oral Surg. Oral Med. Oral Pathol. 1991, 72:270-274.
73. McComb D., Erickson R.L., Maxymiw W.G., Wood R.E. A clinical comparison of glass ionomer, resin-modified glass ionomer and resin composite restorations in the treatment of cervical caries in xerostomic head and neck radiation patients. Oper. Dent. 2002, 27:430-437.
74. Mirabile A., Numico G., Russi E.G., Bossi P., Crippa F., Bacigalupo A., et al. Sepsis in head and neck cancer patients treated with chemotherapy and radiation: Literature review and consensus. Crit. Rev. Oncol. Hematol. 2015, 95:191-213. 10.1016/j.critrevonc.2015.03.003.
75. Mitsuhashi N., Hayakawa K., Hasegawa M., Furuta M., Katano S., Sakurai H., et al. Clinical FDG-PET in diagnosis and evaluation of radiation response of patients with nasopharyngeal tumor. Anticancer Res. 1998, 18:2827-2832.
76. Morrish R.B., Chan E., Silverman S., Meyer J., Fu K.K., Greenspan D. Osteonecrosis in patients irradiated for head and neck carcinoma. Cancer 1981, 47:1980-1983. (19810415) 47:8<1980::AID-CNCR28204708133.0. CO;2-Y. 10.1002/1097-0142.
77. Murthy V., Gupta T., Kadam A., Ghosh-Laskar S., Budrukkar A., Phurailatpam R., et al. Time trial: a prospective comparative study of the time-resource burden for three-dimensional conformal radiotherapy and intensity-modulated radiotherapy in head and neck cancers. J. Cancer Res. Ther. 2009, 5:107-112. 10.4103/0973-1482.52800.
78. Nabil S., Samman N. Incidence and prevention of osteoradionecrosis after dental extraction in irradiated patients: a systematic review. Int. J. Oral Maxillofac. Surg. 2011, 40:229-243. 10.1016/j.ijom.2010.10.005.
79. Nabil S., Samman N. Risk factors for osteoradionecrosis after head and neck radiation: a systematic review. Oral Surg Oral Med Oral Pathol Oral Radiol 2012, 113:54-69. 10.1016/j.tripleo.2011.07.042.
80. National Cancer Institute, 2009. Common Terminology Criteria for Adverse Events v. 4.0.
81. Nguyen T.D., Panis X., Froissart D., Legros M., Coninx P., Loirette M. Analysis of late complications after rapid hyperfractionated radiotherapy in advanced head and neck cancers. Int. J. Radiat. Oncol. Biol. Phys. 1988, 14:23-25.
82. Nooh N. Dental implant survival in irradiated oral cancer patients: a systematic review of the literature. Int. J. Oral Maxillofac. Implants 2013, 28:1233-1242.
83. Nutting C.M., Morden J.P., Harrington K.J., Urbano T.G., Bhide S.A., Clark C., et al. Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial. Lancet Oncol. 2011, 12:127-136. 10.1016/S1470-2045(10)70290-4.
84. Nutting C.M. Intensity modulated radiotherapy (IMRT) in head and neck cancers-an overview. Gulf J. Oncol. 2012, 12:17-26.
85. Oh H.-K., Chambers M.S., Garden A.S., Wong P.-F., Martin J.W. Risk of osteoradionecrosis after extraction of impacted third molars in irradiated head and neck cancer patients. J. Oral Maxillofac. Surg. 2004, 62:139-144. 10.1016/j.joms.2003.08.009.
86. Papas A., Russell D., Singh M., Kent R., Triol C., Winston A. Caries clinical trial of a remineralising toothpaste in radiation patients. Gerodontology 2008, 25:76-88. 10.1111/j.1741-2358.2007.00199.x.
87. Parliament M., Alidrisi M., Munroe M., Wolfaardt J., Scrimger R., Thompson H., et al. Implications of radiation dosimetry of the mandible in patients with carcinomas of the oral cavity and nasopharynx treated with intensity modulated radiation therapy. Int. J. Oral Maxillofac. Surg. 2005, 34:114-121. 10.1016/j.ijom.2004.06.013.
88. Peterson D.E., Doerr W., Hovan A., Pinto A., Saunders D., Elting L.S., et al. Osteoradionecrosis in cancer patients: the evidence base for treatment-dependent frequency, current management strategies, and future studies. Support Care Cancer Off. J. Multinatl. Assoc. Support Care Cancer 2010, 18:1089-1098. 10.1007/s00520-010-0898-6.
89. Pignon J.-P., le Maître A., Maillard E., Bourhis J. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients. Radiother. Oncol. 2009, 92:4-14. 10.1016/j.radonc.2009.04.014.
90. Pow E.H.N., Kwong D.L.W., McMillan A.S., Wong M.C.M., Sham J.S.T., Leung L.H.T., et al. Xerostomia and quality of life after intensity-modulated radiotherapy vs. conventional radiotherapy for early-stage nasopharyngeal carcinoma: initial report on a randomized controlled clinical trial. Int. J. Radiat. Oncol. 2006, 66:981-991. 10.1016/j.ijrobp.2006.06.013.
91. Rankin K.V., Epstein J., Huber M.A., Peterson D.E., Plemons J.M., Redding S.S., et al. Oral health in cancer therapy. Tex. Dent. J. 2009, 126:389-397. 406-19, 422-37.
92. Rankow R.M., Weissman B. Osteoradionecrosis of the mandible. Ann. Otol. Rhinol. Laryngol. 1971, 80:603-611.
93. Regezi J.A., Courtney R.M., Kerr D.A. Dental management of patients irradiated for oral cancer. Cancer 1976, 38:994-1000.
94. Retel V.P., van der Molen L., Hilgers F.J., Rasch C.R., L'ortye A.A., Steuten L.M., et al. A cost-effectiveness analysis of a preventive exercise program for patients with advanced head and neck cancer treated with concomitant chemo-radiotherapy. BMC Cancer 2011, 11:475. 10.1186/1471-2407-11-475.
95. Reuther T., Schuster T., Mende U., Kübler A. Osteoradionecrosis of the jaws as a side effect of radiotherapy of head and neck tumour patients-a report of a thirty year retrospective review. Int. J. Oral Maxillofac. Surg. 2003, 32:289-295. 10.1054/ijom.2002.0332.
96. Reynolds E.C., Cai F., Cochrane N.J., Shen P., Walker G.D., Morgan M.V., et al. Fluoride and casein phosphopeptide-amorphous calcium phosphate. J. Dent. Res. 2008, 87:344-348.
97. Roe J.W.G., Carding P.N., Dwivedi R.C., Kazi R.A., Rhys-Evans P.H., Harrington K.J., et al. Swallowing outcomes following intensity modulated radiation therapy (IMRT) for head & neck cancer-a systematic review. Oral Oncol. 2010, 46:727-733. 10.1016/j.oraloncology.2010.07.012.
98. Sammartino G., Marenzi G., Cioffi I., Teté S., Mortellaro C. Implant therapy in irradiated patients. J. Craniofac. Surg. 2011, 22:443-445. 10.1097/SCS.0b013e318207b59b.
99. Schiødt M., Hermund N.U. Management of oral disease prior to radiation therapy. Support Care Cancer 2002, 10:40-43.
100. Schwartz H.C., Kagan A.R. Osteoradionecrosis of the mandible: scientific basis for clinical staging. Am. J. Clin. Oncol. 2002, 25:168-171.
101. Shaw R.J., Sutton A.F., Cawood J.I., Howell R.A., Lowe D., Brown J.S., et al. Oral rehabilitation after treatment for head and neck malignancy. Head Neck 2005, 27:459-470. 10.1002/hed.20176.
102. Støre G., Boysen M. Mandibular osteoradionecrosis: clinical behaviour and diagnostic aspects. Clin. Otolaryngol. Allied Sci. 2000, 25:378-384.
103. Starcke E.N., Shannon I.L. How critical is the interval between extractions and irradiation in patients with head and neck malignancy?. Oral Surg. Oral Med. Oral Pathol. 1977, 43:333-337.
104. Store G., Larheim T.A. Mandibular osteoradionecrosis: a comparison of computed tomography with panoramic radiography. Dento Maxillo Fac. Radiol. 1999, 28:295-300. 10.1038/sj/dmfr/4600461.
105. Sulaiman F., Huryn J.M., Zlotolow I.M. Dental extractions in the irradiated head and neck patient: a retrospective analysis of memorial sloan-kettering cancer center protocols, criteria, and end results. J. Oral. Maxillofac. Surg. 2003, 61:1123-1131. 10.1016/S0278-2391(03)00669-4.
106. Teguh D.N., Levendag P.C., Voet P., van, der E., st H., Noever I., de K., ruijf W., et al. Trismus in patients with oropharyngeal cancer: relationship with dose in structures of mastication apparatus. Head Neck 2008, 30:622-630. 10.1002/hed.20760.
107. Thorn J.J., Hansen H.S., Specht L., Bastholt L. Osteoradionecrosis of the jaws: clinical characteristics and relation to the field of irradiation. J. Oral Maxillofac. Surg. 2000, 58:1088-1093. 10.1053/joms.2000.9562.
108. Tong A.C., Leung A.C., Cheng J.C., Sham J. Incidence of complicated healing and osteoradionecrosis following tooth extraction in patients receiving radiotherapy for treatment of nasopharyngeal carcinoma. Aust. Dent. J. 1999, 44:187-194.
109. Tsai C.J., Hofstede T.M., Sturgis E.M., Garden A.S., Lindberg M.E., Wei Q., et al. Osteoradionecrosis and radiation dose to the mandible in patients with oropharyngeal cancer. Int. J. Radiat. Oncol. 2013, 85:415-420. 10.1016/j.ijrobp.2012.05.032.
110. Valdez I.H., Atkinson J.C., Ship J.A., Fox P.C. Major salivary gland function in patients with radiation-induced xerostomia: flow rates and sialochemistry. Int. J. Radiat. Oncol. Biol. Phys. 1993, 25:41-47.
111. Van de Water T.A., Bijl H.P., Westerlaan H.E., Langendijk J.A. Delineation guidelines for organs at risk involved in radiation-induced salivary dysfunction and xerostomia. Radiother. Oncol. 2009, 93:545-552. 10.1016/j.radonc.2009.09.008.
112. Van der Laan H.P., van de Water T.A., van Herpt H.E., Christianen M.E.M.C., Bijl H.P., Korevaar E.W., et al. The potential of intensity-modulated proton radiotherapy to reduce swallowing dysfunction in the treatment of head and neck cancer: a planning comparative study. Acta Oncol. 2012, 52:561-569. 10.3109/0284186X.2012.692885.
113. Van der Molen L., van Rossum M.A., Burkhead L.M., Smeele L.E., Hilgers F.J.M. Functional outcomes and rehabilitation strategies in patients treated with chemoradiotherapy for advanced head and neck cancer: a systematic review. Eur. Arch. Otorhinolaryngol. 2009, 266:889-900. 10.1007/s00405-008-0817-3.
114. Van der Molen L., van Rossum M.A., Burkhead L.M., Smeele L.E., Rasch C.R.N., Hilgers F.J.M. A randomized preventive rehabilitation trial in advanced head and neck cancer patients treated with chemoradiotherapy: feasibility, compliance, and short-term effects. Dysphagia 2011, 26:155-170. 10.1007/s00455-010-9288-y.
115. Van der Molen L., Heemsbergen W.D., de Jong R., van Rossum M.A., Smeele L.E., Rasch C.R.N., et al. Dysphagia and trismus after concomitant chemo-intensity-modulated radiation therapy (chemo-IMRT) in advanced head and neck cancer; dose-effect relationships for swallowing and mastication structures. Radiother. Oncol. 2013, 106:364-369. 10.1016/j.radonc.2013.03.005.
116. Vandecaveye V., De Keyzer F., Nuyts S., Deraedt K., Dirix P., Hamaekers P., et al. Detection of head and neck squamous cell carcinoma with diffusion weighted MRI after (chemo) radiotherapy: correlation between radiologic and histopathologic findings. Int. J. Radiat. Oncol. Biol. Phys. 2007, 67:960-971. 10.1016/j.ijrobp.2006.09.020.
117. Visch L.L., van Waas M.A., Schmitz P.I., Levendag P.C. A clinical evaluation of implants in irradiated oral cancer patients. J. Dent. Res. 2002, 81:856-859.
118. Vissink A., Burlage F.R., Spijkervet F.K.L., Jansma J., Coppes R.P. Prevention and treatment of the consequences of head and neck radiotherapy. Crit. Rev. Oral Biol. Med. 2003, 14:213-225. 10.1177/154411130301400306.
119. Wang C.-H., Liang J.-A., Ding H.-J., Yang S.-N., Yen K.-Y., Sun S.-S., et al. Utility of TL-201 SPECT in clarifying false-positive FDG-PET findings due to osteoradionecrosis in head and neck cancer. Head Neck 2010, 32:1648-1654. 10.1002/hed.21377.
120. Wang X., Hu C., Eisbruch A. Organ-sparing radiation therapy for head and neck cancer. Nat. Rev. Clin. Oncol. 2011, (advance online publication). 10.1038/nrclinonc.2011.106.
121. Wood R.E., Maxymiw W.G., McComb D. A clinical comparison of glass ionomer (polyalkenoate) and silver amalgam restorations in the treatment of Class 5 caries in xerostomic head and neck cancer patients. Oper. Dent. 1993, 18:94-102.
122. Worth H.M., Stoneman D.W. Osteomyelitis, malignant disease, and fibrous dysplasia. Some radiologic similarities and differences. Dent. Radiogr. Photogr. 1977, 8:12-15.
123. Yerit K.C., Posch M., Seemann M., Hainich S., Dörtbudak O., Turhani D., et al. Implant survival in mandibles of irradiated oral cancer patients. Clin. Oral Implants Res. 2006, 17:337-344. 10.1111/j.1600-0501.2005.01160.x.
124. Yusof Z.W., Bakri M.M. Severe progressive periodontal destruction due to radiation tissue injury. J. Periodontol. 1993, 64:1253-1258. 10.1902/jop.1993.64.12.1253.